Hospira Inc-Strategy, SWOT and Corporate Finance Report

Hospira Inc-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Hospira Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Hospira Inc in the form of a SWOT analysis

An in-depth view of the business model of Hospira Inc including a breakdown and examination of key business segments

Intelligence on Hospira Inc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Hospira Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Hospira Inc and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Hospira Inc as a prospective partner, vendor or supplier

Support sales activities by understanding your customers’ businesses better

Stay up to date on Hospira Inc’s business structure, strategy and prospects

Key Highlights

Hospira (or ‘the company’) is a leading provider of injectable drugs and infusion technologies. It develops, manufactures and markets products including generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. The company operates in the Americas, Europe, Middle East, Africa and Asia-Pacific regions. It is headquartered in Lake Forest, Illinois, and employed about 17,000 people as on December 31, 2013.